納微科技(688690.SH)首日上市暴漲1273.98% 換手率高達80.25%
格隆匯6月23日丨納微科技(688690.SH)首日上市盤中一度漲1398.14%報120.9元,最終收漲1273.98%報110.88元,全天成交27億元,換手率高達80.25%,最新市值444億元。納微科技是一家專門從事高性能納米微球材料研發、規模化生產、銷售及應用服務的高新技術企業。被稱為納米微球第一股。2018-2020年,納微科技營收和淨利潤均呈上升趨勢,營收分別為0.82億元、1.3億元、2.04億元;淨利潤為1378萬元、2140萬元、7290萬元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.